Radicava IV
RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
RADICAVA® (edaravone) IV is an intravenous medication for the treatment of amyotrophic lateral sclerosis (ALS). This means that RADICAVA® IV is given through a needle in a vein.
RADICAVA® IV is given through a vein as an infusion. The initial treatment cycle starts with daily dosing of RADICAVA® IV for 14 days followed by a 14-day drug-free period. Subsequent treatment cycles include daily dosing 10 out of 14 days followed by a 14-day drug-free period.
Radicava may cause serious side effects including:
The most common side effects of Radicava include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.